Ning has over 15 years of working experience in innovative drug research and development management in CMC, pre-clinical, and PPM (portfolio project management). Under her leadership and participation, she completed one of the "13th Five Year Plan National Major New Drug Creation" projects, two Shanghai biopharmaceutical support projects, and other science and technology special funds. Before Impact, she worked for GSK plc (China) R&D Center and Roche R&D (China) Co., Ltd., engaged in medicinal chemistry research. Ms. Ma obtained a Master of Science degree from Zhengzhou University and an EMBA degree from China Europe Business School (CEIBS).
Copyright (c) 2013 IMPACT Therapeutics. All Rights Reserved 沪ICP备2024107649号 互联网药品信息证书编号:(沪)-非经营性-2025-0012 /Clinical Trial Privacy Notice / Privacy Notice / Legal Statement